Clinical Trials Directory

Trials / Conditions / Refractory Peripheral T-Cell Lymphoma

Refractory Peripheral T-Cell Lymphoma

6 registered clinical trials studyying Refractory Peripheral T-Cell Lymphoma — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingPralatrexate Combined With Chidamide Bridging Allogeneic HSCT for Refractory/Relapsed Peripheral T-cell Lympho
NCT06671717
Peking University People's HospitalN/A
RecruitingPembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell Lymphoma
NCT06160843
National Cancer Centre, SingaporePhase 2
CompletedStudy of Brentuximab Vedotin in Patients With R/R PTCL Treated With Gemcitabine
NCT03496779
The Lymphoma Academic Research OrganisationPhase 2
CompletedA Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory
NCT03349333
Mundipharma (China) Pharmaceutical Co. LtdPhase 3
CompletedPhase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignanc
NCT02106650
Acrotech Biopharma Inc.Phase 2
CompletedAlisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
NCT01482962
Millennium Pharmaceuticals, Inc.Phase 3